![Navid Ashrafi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 366 141 $ al 30/06/2026
Navid Ashrafi is currently the Director-Medical & Regulatory Affairs at BioSyent, Inc. He previously worked as the Head-Business Unit at Bayer Parsian AG.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOSYENT INC. 0,31 % | 30/06/2026 | 35.861 ( 0,31 % ) | 366 141 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOSYENT INC. | Director Técnico/Científico/I+D | 01/06/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
Bayer Parsian AG
 Bayer Parsian AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
BioSyent, Inc.
 BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Bayer Parsian AG
Bayer Parsian AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
